Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ritchie

Showing results (461-470 of 502) with videos related to

Pageof 51
Sort By:
Metallurgical and Materials Transactions. A. Physical Metallurgy and Materials Science|October 16, 2020
Solidification of Ni-Re Peritectic AlloysW J Boettinger, D E Newbury, N W M Ritchie, et al.
Drug Design and Discovery|January 1, 1993
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blockerJ H Dodd, C F Schwender, R A Conley, et al.
Neurology|March 12, 2010
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosisS A Sargsyan, A J Shearer, A M Ritchie, et al.
British Journal of Cancer|July 31, 2008
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluationA M Wardley, L Hiller, H C Howard, et al.
Cellular Microbiology|December 11, 2007
EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7Jennifer M Ritchie, Michael J Brady, Kathleen N Riley, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammationT Kirchner, D C Argentieri, A G Barbone, et al.
Journal for Immunotherapy of Cancer|January 22, 2021
Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapySophie M Poznanski, Tyrah M Ritchie, Isabella Y Fan, et al.
The Journal of Prevention of Alzheimer'S Disease|November 19, 2024
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease TrialM Ritchie, R Raman, K Ernstrom, et al.
Nature Communications|February 5, 2024
Bystander activated CD8<sup>+</sup> T cells mediate neuropathology during viral infection via antigen-independent cytotoxicityElizabeth Balint, Emily Feng, Elizabeth C Giles, et al.
Injury|April 19, 2014
Patient preferences and acceptable risk for computed tomography in traumaRobert M Rodriguez, Tarann M Henderson, Anne M Ritchie, et al.
Pageof 51

Showing results (461-470 of 502) with videos related to

Sort By:
Pageof 51
Metallurgical and Materials Transactions. A. Physical Metallurgy and Materials Science|October 16, 2020
Solidification of Ni-Re Peritectic AlloysW J Boettinger, D E Newbury, N W M Ritchie, et al.
Drug Design and Discovery|January 1, 1993
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blockerJ H Dodd, C F Schwender, R A Conley, et al.
Neurology|March 12, 2010
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosisS A Sargsyan, A J Shearer, A M Ritchie, et al.
British Journal of Cancer|July 31, 2008
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluationA M Wardley, L Hiller, H C Howard, et al.
Cellular Microbiology|December 11, 2007
EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7Jennifer M Ritchie, Michael J Brady, Kathleen N Riley, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammationT Kirchner, D C Argentieri, A G Barbone, et al.
Journal for Immunotherapy of Cancer|January 22, 2021
Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapySophie M Poznanski, Tyrah M Ritchie, Isabella Y Fan, et al.
The Journal of Prevention of Alzheimer'S Disease|November 19, 2024
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease TrialM Ritchie, R Raman, K Ernstrom, et al.
Nature Communications|February 5, 2024
Bystander activated CD8<sup>+</sup> T cells mediate neuropathology during viral infection via antigen-independent cytotoxicityElizabeth Balint, Emily Feng, Elizabeth C Giles, et al.
Injury|April 19, 2014
Patient preferences and acceptable risk for computed tomography in traumaRobert M Rodriguez, Tarann M Henderson, Anne M Ritchie, et al.
Pageof 51